It has been 35 years since GLP-1 was discovered, and it is no longer a new target, but its long-acting effect is far from over
342 Sgaard, S
These symptoms typically emerge during dose escalation and often diminish over 4-8 weeks as tolerance develops
In double-blind, placebo-controlled trials, daily application of GHK-Cu cream at 3% concentration for 12 weeks produced a 70% increase in skin collagen thickness as measured by ultrasound imaging, a 40% increase in skin elasticity, and visible reduction in fine lines and wrinkles
Its medication-aware, meaning it understands your dose schedule and frames your Oura data through that lens, so patterns that might look confusing in isolation suddenly make sense in context
This is in line with data after subcutaneous administration which showed that intact semaglutide in urine accounted for 3.1% of the administered dose in humans, less than 1% in rats and was not detected in the urine in monkeys [28]